TrialBlood cancer journal2021

Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia.

Hee-Je Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.